Cat.#: ACPP-1237
| Despition | CRMP1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1794 | Human BAIAP2 Protein (AC1794) | 5 µg | inquiry |
| ACPP-1694 | Mouse FGF 1 Protein, His (AC1694) | 5 µg | inquiry |
| ACPP-1644 | Human Vimentin Protein (AC1644) | 20 µg | inquiry |
| ACPP-1564 | Human EIF3K Protein (AC1564) | 2 µg | inquiry |
| ACPP-1218 | Dopamine D2 Receptor Blocking Peptide (AC1218) | 250 µg | inquiry |
| ACPP-1814 | PPA E.Coli (AC1814) | 5 µg | inquiry |
| ACPP-1290 | Insulin Receptor Blocking Peptide (AC1290) | 250 µg | inquiry |
| ACPP-1722 | Human SRR Protein (AC1722) | 1 µg | inquiry |
| ACPP-1353 | PDE7B Blocking Peptide (AC1353) | 250 µg | inquiry |
| ACPP-1263 | MAPK7 Blocking Peptide (AC1263) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.